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background: Presence of left ventricular hypertrophy (LVH) has been shown to increase risk of sudden death and to be associated with clinically 
significant arrhythmias. However, the association has not been systematically quantified and evaluated.
methods: A systematic search of studies published between January 1, 1966 and February 1, 2013, was conducted using MEDLINE, EMBASE, 
CINAHL, Scopus, Web of Science, and Cochrane Central Register of Controlled Trials databases. Studies reporting on clinically significant arrhythmias 
like atrial fibrillation and other supraventricular tachycardias (SVT) and ventricular arrhythmias - tachycardia and fibrillation (VT/VF) were identified. 
Two authors independently reviewed 468 originally identified titles and abstracts and selected 12 for pooled analysis. Pooled effect estimates were 
calculated with random effects (DerSimonian and Laird) models.
results: There was a 3-fold higher odds of detecting SVT in association with presence of LVH (odds ratio-OR 3.39; 95% CI 1.57-7.31), although 
significant heterogeneity was present (I2=98%). There was also a 3-fold higher odds of detecting VT/VF, in association with presence of LVH (OR 
2.83; 95% CI 1.78- 4.51), no significant heterogeneity being present (I2=9%).
conclusion: Presence of LVH is associated with clinically significant supraventricular/atrial and ventricular arrhythmias. Whether or not these 
arrhythmias allow us to identify patients at increased risk for sudden death remains to be determined.
 
